We describe here the potential of viral-mediated gene transfer for the modeling and treatment of Huntington’s disease, focusing in particular on strategies for the tissue-specific targeting of various CNS cells. The protocols described here cover the design of lentiviral vectors, strategies for modifying their tropism, including the use of various envelopes and tissue-specific promoters, and the potential of miRNA to regulate transgene expression.
CITATION STYLE
Delzor, A., Dufour, N., & Déglon, N. (2014). Lentiviral vectors in Huntington’s disease research and therapy. Neuromethods, 82, 193–220. https://doi.org/10.1007/978-1-62703-610-8_11
Mendeley helps you to discover research relevant for your work.